Series C - InCarda Therapeutics
Investment Firm
Overview
Incarda Therapeutics offers a novel approach to treat cardiovascular conditions and diseases by the inhalation route.
Announced Date
Oct 21, 2020
Closed on Date
Oct 21, 2020
Funding Type
Series C
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 HealthCap |
 Deerfield |
Round Details and Background
InCarda Therapeutics raised $30000000 on 2020-10-21 in Series C
Incarda Therapeutics offers a novel approach to treat cardiovascular conditions and diseases by the inhalation route.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 01, 2017 |  Venture Round - InCarda Therapeutics | 1 | - | undefined |
| Jul 12, 2016 | Venture Round - InCarda Therapeutics | 1 | - | undefined |
| Apr 28, 2015 | Series A - InCarda Therapeutics | 1 | - | 5.0M |
| Oct 17, 2012 | Debt Financing - InCarda Therapeutics | - | 310.0K |
Recent Activity
There is no recent news or activity for this profile.